Latest AMGN Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Hold | - | |
| NASDAQ:AMGN | Investing.com | Initiates Coverage | Hold | - | |
| Urmimala Biswas | Zacks Equity Research | Initiates Coverage | Hold | - | |
| Kinjel Shah | Zacks Equity Research | Initiates Coverage | Hold | - | |
| Aparajita Dutta | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Salim Syed | Mizuho | Maintains | Hold | $303.00 → $352.00 +49.00 (16.2%) | |
| Emily Field | Barclays | Maintains | Hold | $360.00 → $380.00 +20.00 (5.6%) | |
| Geoff Meacham | Citi | Maintains | Hold | $345.00 → $405.00 +60.00 (17.4%) | |
| Vamil Divan | Guggenheim | Maintains | Hold | $343.00 → $388.00 +45.00 (13.1%) | |
| Chris Schott | JP Morgan | Maintains | Hold | $350.00 | |
| Google Drug Manufacturers - General | TipRanks - Google | Reiterates | Buy | $424.00 → $449.00 +25.00 (5.9%) | |
| PerPlexity Drug Manufacturers - General | TipRanks - PerPlexity | Reiterates | Buy | $426.00 → $450.00 +24.00 (5.6%) | |
| Anthropic Drug Manufacturers - General | TipRanks - Anthropic | Reiterates | Hold | $393.00 → $411.00 +18.00 (4.6%) | |
| DeepSeek Drug Manufacturers - General | TipRanks - DeepSeek | Reiterates | Buy | $418.00 → $456.00 +38.00 (9.1%) | |
| xAi Drug Manufacturers - General | TipRanks - xAI | Reiterates | Buy | $429.00 → $452.00 +23.00 (5.4%) | |
| DefenseMania | StockTwits | Initiates Coverage | Buy | - | |
| Gary Nachman | Canaccord Genuity | Maintains | Hold | $366.00 → $384.00 +18.00 (4.9%) | |
| OpenAI Drug Manufacturers - General | TipRanks - OpenAI | Reiterates | Buy | $416.00 → $439.00 +23.00 (5.5%) | |
| Courtney Breen | Bernstein | Maintains | Hold | $335.00 → $345.00 +10.00 (3.0%) | |
| Salveen Richter | Goldman Sachs | Maintains | Buy | $427.00 → $450.00 +23.00 (5.4%) | |
| Tazeen Ahmad | BofA Securities | Reiterates | Sell | $312.00 → $317.00 +5.00 (1.6%) | |
| Michael Yee | UBS | Maintains | Buy | $420.00 → $440.00 +20.00 (4.8%) | |
| Brian Skorney | Baird | Maintains | Sell | $215.00 → $230.00 +15.00 (7.0%) | |
| Jay Olson | Oppenheimer | Maintains | Buy | $400.00 → $450.00 +50.00 (12.5%) | |
| Luca Issi | RBC Capital | Maintains | Buy | $370.00 → $400.00 +30.00 (8.1%) | |
| Sundeep Ganoria | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Tazeen Ahmad | BofA Securities | Reiterates | Sell | $307.00 → $312.00 +5.00 (1.6%) | |
| Evan Seigerman | BMO Capital | Maintains | Buy | $400.00 | |
| Michael Yee | UBS | Reiterates | Buy | $400.00 → $420.00 +20.00 (5.0%) | |
| Mohit Bansal | Wells Fargo | Maintains | Hold | $390.00 | |
| Vamil Divan | Guggenheim | Maintains | Hold | $340.00 → $343.00 +3.00 (0.9%) | |
| Terence Flynn | Morgan Stanley | Maintains | Hold | $340.00 → $333.00 -7.00 (-2.1%) | |
| Gregory Renza | Truist | Maintains | Hold | $327.00 → $340.00 +13.00 (4.0%) | |
| Luca Issi | RBC Capital | Maintains | Buy | $370.00 | |
| Google Drug Manufacturers - General | TipRanks - Google | Reiterates | Buy | $412.00 | |
| PerPlexity Drug Manufacturers - General | TipRanks - PerPlexity | Reiterates | Buy | $413.00 | |
| Anthropic Drug Manufacturers - General | TipRanks - Anthropic | Reiterates | Hold | $382.00 | |
| DeepSeek Drug Manufacturers - General | TipRanks - DeepSeek | Reiterates | Hold | $406.00 | |
| Evan Seigerman | BMO Capital | Maintains | Buy | $400.00 | |
| David Amsellem | Piper Sandler | Reiterates | Buy | $427.00 | |
| Salim Syed | Mizuho | Maintains | Hold | $303.00 | |
| Salim Syed | Mizuho | Maintains | Hold | $303.00 | |
| Luca Issi | RBC Capital | Reiterates | Buy | $370.00 | |
| Salim Syed | Mizuho | Maintains | Hold | $295.00 → $303.00 +8.00 (2.7%) | |
| David Amsellem | Piper Sandler | Reiterates | Buy | $427.00 |
